NPI Details
DIAGNOSTIC CYTOGENETICS is a clinical medical laboratory in Seattle, WA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. DIAGNOSTIC CYTOGENETICS NPI is 1104899376. The provider is registered as an organization entity type.
The provider's business location address is:
2360 W COMMODORE WAY STE 201
SEATTLE, WA
ZIP 98199-285
Phone: (206) 328-2026
Fax: (206) 325-2975
The provider's authorized official is Kyndra M Mcdougal .
The authorized official title is Chief Regulatory Officer and has the following contact phone number (888) 618-9107.
The CLIA number assigned to this NPI record is 50D0721329 - independent with a certificate type of Certificate of Accreditation.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
- Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
- Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
- Analysis of urine, except immunoassays (HCPCS:81005)
- Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
- Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
- Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
- Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
- Interpretation and report of genetic testing (HCPCS:88291)
- Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
- Tissue culture for tumor disorders of bone marrow and blood cells (HCPCS:88237)
- Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique (HCPCS:87496)
- Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
- Chromosome analysis for genetic defects, additional karyotypes, each study (HCPCS:88280)
- Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
- Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
- Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
- Chromosome analysis for genetic defects, analyze 20-25 cells (HCPCS:88264)
- Pap test (HCPCS:88141)
- Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
- Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
- Chromosome analysis for genetic defects, additional cells counted, each study (HCPCS:88285)
- Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
- Chromosome analysis for genetic defects, count 5 cells (HCPCS:88261)
The enumeration date for this NPI number is 2/8/2006 and was last updated on 2/16/2023.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | MTS-0439 | WASHINGTON | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 7271406 | MEDICAID | WASHINGTON | |
